Pacira BioSciences PCRX
NASDAQ PCRX
$25.18 -0.47 (-1.83%)
As of: Sep 30, 2026 · 3:53 PM EDT

Pacira BioSciences (PCRX) Operating Expenses (2010 - 2026)

Updated

Pacira BioSciences (PCRX) posted Operating Expenses of $188.13 million for Q2 2026, up 9.0% from $172.6 million a year earlier and up 10.4% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Operating Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Pacira BioSciences was $726.29 million, down 10.4% year-over-year; for FY2025, it came in at $707.22 million, down 8.7% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
  • In prior years, Pacira BioSciences' Operating Expenses was $774.34 million in FY2024 (+31.8%), $587.3 million in FY2023 (-3.2%), $606.8 million in FY2022 (+34.4%) and $451.61 million in FY2021 (+17.8%).
  • Quarterly Operating Expenses has run from a low of $96.29 million in Q3 2021 to a high of $308.1 million in Q3 2024 over five years.
  • On a year-over-year basis, Operating Expenses has increased in each of the last three quarters, with growth averaging 16.4% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q3 2024, with growth of 110.7%; the weakest was Q3 2025, with a decline of 43.8%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $170.47 million (Q1 2026), $194.53 million (Q4 2025) and $173.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Pacira BioSciences 1.02 Bn 83.47 Mn 148.24 Mn 188.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 188.13 Mn
Mar 31, 2026 170.47 Mn
Dec 31, 2025 194.53 Mn
Sep 30, 2025 173.15 Mn
Jun 30, 2025 172.60 Mn
Mar 31, 2025 166.93 Mn
Dec 31, 2024 162.55 Mn
Sep 30, 2024 308.10 Mn
Jun 30, 2024 149.78 Mn
Mar 31, 2024 153.91 Mn
Dec 31, 2023 148.08 Mn
Sep 30, 2023 146.21 Mn
Jun 30, 2023 129.59 Mn
Mar 31, 2023 163.43 Mn
Dec 31, 2022 181.85 Mn
Sep 30, 2022 146.18 Mn
Jun 30, 2022 138.18 Mn
Mar 31, 2022 140.60 Mn
Dec 31, 2021 154.98 Mn
Sep 30, 2021 96.29 Mn
API Access

Pacira BioSciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=PCRX&period=max&api_key=YOUR_API_KEY